Patents by Inventor Andrew Philip Lowry

Andrew Philip Lowry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunoassay for compounds of the NBOMe family
    Patent number: 9720005
    Abstract: An immunoassay method for detecting and determining ‘NBOMe’ family designer drugs is described. Also described are components for use in implementing the method, namely, antibodies, detection agents, solid state devices and kits as well as immunogens used to raise the antibodies.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: August 1, 2017
    Assignee: Randox Laboratories Limited
    Inventors: Ivan Robert McConnell, Elouard Benchikh, Peter Fitzgerald, Andrew Philip Lowry
  • IMMUNOASSAY FOR COMPOUNDS OF THE NBOMe FAMILY
    Publication number: 20150346226
    Abstract: An immunoassay method for detecting and determining ‘NBOMe’ family designer drugs is described. Also described are components for use in implementing the method, namely, antibodies, detection agents, solid state devices and kits as well as immunogens used to raise the antibodies.
    Type: Application
    Filed: May 28, 2015
    Publication date: December 3, 2015
    Inventors: Ivan Robert McConnell, Elouard Benchikh, Peter Fitzgerald, Andrew Philip Lowry
  • Sensitive and generic antibodies and multiple applications
    Patent number: 8735556
    Abstract: The invention relates to the detection and quantification of carbamazepine drugs and their metabolites. The invention is underpinned by novel polyclonal antibodies with unique binding properties which enable immunoassay methods and kits for various applications.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: May 27, 2014
    Assignee: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Andrew Philip Lowry, Ivan McConnell, Peter Stephen Fitzgerald
  • SENSITIVE AND GENERIC ANTIBODIES AND MULTIPLE APPLICATIONS
    Publication number: 20120322089
    Abstract: The invention relates to the detection and quantification of carbamazepine drugs and their metabolites. The invention is underpinned by novel polyclonal antibodies with unique binding properties which enable immunoassay methods and kits for various applications.
    Type: Application
    Filed: June 18, 2012
    Publication date: December 20, 2012
    Applicant: Randox Laboratories Limited
    Inventors: Elouard Benchikh, Andrew Philip Lowry, Ivan McConnell, Peter Stephen Fitzgerald
  • Phenethanolamine-derived haptens, immunogens, antibodies and conjugates
    Patent number: 7192722
    Abstract: The present invention relates to a method for preparing haptens of formulae I and II that are useful in the preparation of immunogens, antibodies and conjugates, for use in competitive immunoassays for the detection of ractopamine, isoxsuprine and ritodrine. The haptens are prepared by reacting a phenylethanolamine derivative of formula D with a phenylalkylcarbonyl derivative of formula E: in which, in formula I, Z1 is a crosslinker and Z2 is H and, in formula II, Z1 is H and Z2 is a crosslinker.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: March 20, 2007
    Assignee: Randox Laboratories
    Inventors: Robert Ivan McConnell, Stephen Peter Fitzgerald, El Ouard Benchikh, Andrew Philip Lowry
  • Haptens, immunogens and antibodies to oxycodone and its metabolites
    Patent number: 7026134
    Abstract: Novel haptens, which can be conjugated to form immunogens, are of formula I, II or III wherein R is a divalent alkyl, cycloalkyl or aryl group having 1 to 10 carbon atoms, and X is a functional group.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: April 11, 2006
    Assignee: Randox Laboratories Ltd.
    Inventors: John Victor Lamont, Robert Ivan McConnell, Stephen Peter Fitzgerald, El Ouard Benchikh, Andrew Philip Lowry
  • Haptens, immunogens and antibodies to oxycodone and its metabolites
    Publication number: 20030157565
    Abstract: Novel haptens, which can be conjugated to form immunogens, are of formula I, II or III 1
    Type: Application
    Filed: December 20, 2002
    Publication date: August 21, 2003
    Applicant: RANDOX LABORATORIES LTD.
    Inventors: John Victor Lamont, Robert Ivan McConnell, Stephen Peter Fitzgerald, El Ouard Benchikh, Andrew Philip Lowry